At 8:23AM, the early indicator SGX Nifty was down 61 points at 8,355.
Oil prices slumped to new 5-1/2-year lows on Monday on worries about a surplus of global supplies and lacklustre demand. The two crude oil benchmarks - Brent and U.S. light crude, also known as West Texas Intermediate - have now lost more than half of their value since mid-2014.
On the political front, the Union Cabinet on Monday finalised the reserve prices for the 800-, 900- and 1,800-MHz telecom spectrum bands and said the 2,100-MHz band would be auctioned simultaneously with the other bands in February. Also, the Cabinet has approved an ordinance for the auction of iron ore and other minerals.
Among Asian markets, Japan's Nikkei share average tumbled 2.6% on Tuesday as concerns over Greece's future in the euro zone and weak oil prices curbed risk appetite, while the strong yen dragged down exporters. Hang Seng index has lost close to 1%. However, Shanghai Composite index is trading against the global trend and is up by 0.7% as the Chinese HSBC Services PMI for the month of December at 53.4 is at a three-month high.
Overnight, US markets experienced sharp selling pressure particularly in the energy stocks as global crude prices slumped further. The U.S. S&P 500 had its worst day in almost three months on Monday, dropping 1.8% while Dow Jones Industrial Average declined around 1.9% and Nasdaq Composite lost nearly 1.6%.
Meanwhile, foreign institutional investors were net buyers in Indian equities worth Rs 472 crore on Monday, as per provisional stock exchange data.
Stocks to watch
Sustained fall in global crude oil prices will bring the focus on oil marketing companies like IOC, BPCL and HPCL.
Bajaj Corp will be in focus as RBI has allowed foreign investors to buy up to 49% of its paid-up capital.
IDBI Bank is in focus on media reports that the public-sector bank is planning to raise Rs 2,600 crore by infrastructure bonds with a 10-year maturity.
GMR Infrastructure is in focus on media reports the civil aviation ministry is to offer the contract for building and running the proposed Jewar airport in Greater Noida to the GMR Group.
Jubilant Life Sciences will attract investors as the pharma company has received approval from US FDA to lauch generic versions of Mycophenolate Mofetil, an immuno-suppressant, and Rizatriptan, used for treatment of migraine, in the American market.
Deepak Fertilisers, which is in the middle of a year-long battle to acquire Mangalore Chemicals and Fertilizers, has sold over two per cent stake in the takeover target in nine tranches during the past month.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)